AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 165 filers reported holding AKERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,265,410 | -66.4% | 25,018 | -68.9% | 0.00% | -66.7% |
| Q2 2023 | $3,761,533 | +66783.6% | 80,564 | +54705.4% | 0.01% | – |
| Q1 2023 | $5,624 | -99.9% | 147 | -99.9% | 0.00% | -100.0% |
| Q4 2022 | $6,829,614 | +341380.7% | 124,628 | +226496.4% | 0.02% | – |
| Q3 2022 | $2,000 | -75.0% | 55 | -93.1% | 0.00% | – |
| Q2 2022 | $8,000 | -94.0% | 800 | -91.5% | 0.00% | – |
| Q1 2022 | $133,000 | -89.6% | 9,400 | -78.6% | 0.00% | -100.0% |
| Q1 2021 | $1,273,000 | +63550.0% | 43,885 | +66392.4% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | -96.4% | 66 | -97.0% | 0.00% | – |
| Q2 2020 | $55,000 | -24.7% | 2,204 | -35.9% | 0.00% | -100.0% |
| Q1 2020 | $73,000 | – | 3,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |